Successful treatment of refractory amyopathic dermatomyositis with upadacitinib in prior JAK inhibitor failure

JAAD Case Rep. 2024 Jul 8:51:97-99. doi: 10.1016/j.jdcr.2024.06.033. eCollection 2024 Sep.

Authors

Alice Sohn¹, Nicole Bouché², George Michael Lewitt³, Eingun James Song¹

Affiliations

¹ Frontier Dermatology, Mill Creek, Washington.
² Elson S. Floyd College of Medicine, Spokane, Washington.
³ Illinois Dermatology Institute, Chicago, Illinois.

No abstract available

Keywords: Medical Dermatology; biologics; clinical research; dermatomyositis; drug response; general dermatology; immunodermatology; upadacitnib.

Publication types

Case Reports